Patents by Inventor Oliver Lade

Oliver Lade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11954178
    Abstract: A computer-implemented method is for providing radiomics-related information. In an embodiment, the computer-implemented method includes receiving radiomics-related data; determining, based on the radiomics-related data and an assistance algorithm, a function for processing the radiomics-related data; calculating, based on the radiomics-related data and the function for processing the radiomics-related data, the radiomics-related information; and providing the radiomics-related information.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: April 9, 2024
    Assignee: Siemens Healthineers AG
    Inventors: Alexander Muehlberg, Oliver Taubmann, Alexander Katzmann, Felix Durlak, Michael Wels, Felix Lades, Rainer Kaergel, Michael Suehling
  • Publication number: 20210087481
    Abstract: Disclosed is a process for the production of synthesis gas by plasma gasification of solid and/or liquid carbon-containing or hydrocarbon-containing material comprising the steps: (i) providing a solid and/or liquid feedstock comprising particulate carbon- or hydrocarbon-containing material or a mixture of both, (ii) providing a carrier gas and combining this with the solid or liquid feedstock, (iii) feeding said solid or liquid feedstock and said carrier gas as a feed stream into a reactor comprising a reaction chamber or into a vaporizer which is arranged upstream to said reactor, (iv) introducing a swirl gas into the reactor which swirls around the feed stream and covers the interior walls of the reactor, (v) treating said feed stream downstream the introduction of the swirl gas into the reactor with a hot plasma to generate a product stream comprising synthesis gas from said carbon- or hydrocarbon-containing material in the reaction chamber, (vi) removing the product stream from the reaction chamber, and
    Type: Application
    Filed: December 13, 2018
    Publication date: March 25, 2021
    Applicant: Clariant International Ltd.
    Inventors: Christian DREISER, Olaf WACHSEN, Oliver LADE, Stefan BRAND, Georgios STEFANIDIS
  • Publication number: 20130225416
    Abstract: A method for sequencing nucleic acid molecules a) amplifies nucleic acid molecules and b) sequences the amplified nucleic acid molecules. Steps (a) and (b) are carried out on an array of field effect transistor (FET) sensor elements, comprising an array of nanowires. Within the array, each FET may include at least one nanowire, or one each FETs can lie between two nanowires, or one nanowire of a nanowire pair is a nanowire FET, with nucleic acids bound to a nanowire surface. A chip includes one or more arrays of field effect transistor sensor elements. A kit for sequencing nucleic acid molecules, may include one or more amplifying reagents or sequencing reagents.
    Type: Application
    Filed: November 29, 2012
    Publication date: August 29, 2013
    Inventors: Gabriela ALTMANN, Oliver HAYDEN, Oliver LADE, Christian P. SCHULTZ, Gerald WARNAT
  • Publication number: 20120232250
    Abstract: A method for producing a radioactively marked peptide, uses a precursor molecule that is prepared in an organic solvent. A radioactively marked compound having a carboxyl function is added. The carboxyl function is activated, and the activated radioactively marked compound is bonded to the precursor molecule in order to form the radioactively marked peptide. The radioactively marked compound is an isocyanocarboxylic acid. A radioactively marked isocyanocarboxylic acid is used for producing a radioactively marked peptide.
    Type: Application
    Filed: July 7, 2010
    Publication date: September 13, 2012
    Inventors: Markus Kinzl, Oliver Lade, Arno Steckenborn
  • Publication number: 20120186988
    Abstract: A method produces a radioactively marked carboxylate, at least one precursor molecule of the carboxylate being prepared in a solvent including a conductive salt. Radioactively marked carbon dioxide is fed into the solvent. The precursor molecule is electrochemically reacted with the radioactively marked carbon dioxide to form the radioactively marked carboxylate. The radioactively marked carbon dioxide is completely dissolved in the solvent when the precursor molecule is reacted. The radioactively marked carbon dioxide is used for electrochemically synthesizing a radioactively marked carboxylate, the carbon dioxide being completely dissolved in a solvent during synthesis. A microstructure is used for electrochemically synthesizing the radioactively marked carboxylate, radioactively marked carbon dioxide being reacted.
    Type: Application
    Filed: July 7, 2010
    Publication date: July 26, 2012
    Applicant: Siemens Aktiengesellschaft
    Inventors: Markus Kinzl, Oliver Lade, Christian P. Schultz, Arno Steckenborn, Frank Thalmann
  • Publication number: 20120183473
    Abstract: A therapeutically active ingredient is administered to the human or animal body. The active ingredient contains an ?-hydroxy acid, an ?-amino acid, a peptide or a protein, the component being radiolabeled with 11C and the radioactive atom replacing the C atom of the carboxyl group or of a peptide bond in the a position. The labeled therapeutically active ingredient which is chemically identical to the active ingredient to be used for therapeutic purposes can be advantageously used in tests which allow a dispersion of the active ingredient to be tested in tissue samples or in the human or animal body by positron emission tomography. The complementary information can for example help to accelerate the approval procedure for medicaments.
    Type: Application
    Filed: July 13, 2010
    Publication date: July 19, 2012
    Applicant: SIEMENS AKTIENGESELLSCHAFT
    Inventors: Oliver Lade, Arno Steckenborn
  • Publication number: 20120142961
    Abstract: A method produces a radiopharmaceutical. In the method, an H—Li exchange is made by adding an alkyllithium to an isocyanide, wherein the ?-H atom of the isocyanide is replaced with an Li atom. 11CO2 is added and bonded to the ?-C atom of the isocyanide. By a two-stage hydrolysis, the Li atom is replaced with an H atom and an amino group is formed from the isocyanide group, for example, by adding NH4Cl and HI. The reaction is continuously performed in particular in a microfluidic structure so that reaction times of less than 300 seconds can be achieved for the partial steps. Because the produced radiopharmaceutical has only a low half-life, the short production time has a positive effect on the yield of radioactive pharmaceutical.
    Type: Application
    Filed: March 31, 2010
    Publication date: June 7, 2012
    Applicant: SIEMENS AKTIENGESELLSCHAFT
    Inventors: Markus Kinzl, Oliver Lade, Christan P. Schultz, Amo Steckenborn, Frank Thalmann
  • Publication number: 20120071647
    Abstract: A microfluidic reactor has a reaction chamber which is configured as an annular channel. It is provided that segments have been formed in the annular channel such that a sequence of inlets and outlets (allows an alternation between the process fluids (A and B) to take place. Furthermore, particles which circulate in the annular channel and can be used, for example, for the adsorption and desorption of ions may be provided in the annular channel. In this way, the ions concerned can, for example, be extracted from the process fluid (A) and transferred into the process fluid (B). In a method, the reactor can be used for example for the purpose of obtaining 18F? ions from water enriched therewith and feeding them to a solvent such as acetonitrile. In the further course of the method, the 18F? ions can be used for producing a radiopharmaceutical (for example FDG).
    Type: Application
    Filed: May 12, 2010
    Publication date: March 22, 2012
    Inventors: Oliver Lade, Arno Steckenborn
  • Publication number: 20100300869
    Abstract: The invention involves a micro-fluidic separation device for liquid mixtures with different boiling points. According to the invention it is intended that a head and a sump are formed in a separating channel; further intended is a thermo unit along the entire length of the separating channel consisting preferably of individually controllable heating and/or cooling elements. This makes it advantageously possible to perform a rectification of the liquid mixture with the separating device where individual fractions of the liquid mixture may be removed via the outlets. This allows continuous operations of the separating device at a simultaneously high degree of efficiency of the separation.
    Type: Application
    Filed: June 1, 2010
    Publication date: December 2, 2010
    Applicant: SIEMENS AKTIENGESELLSCHAFT
    Inventors: Hans-Richard Kretschmer, Oliver Lade, Arkadij M. Elizarov